Compare American Well Corp (AMWL) vs Morgan Stanley (MS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Morgan Stanley — how do they compare? American Well Corp trades at $10.4 (market cap $165.58M), while Morgan Stanley trades at $220.98 (market cap $350.60B). The key difference: Morgan Stanley is far larger — about 2117.4× American Well Corp's market cap, and Morgan Stanley pays a 1.8% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | MS | |
|---|---|---|
Market Cap | $165.58M | $350.60B |
Sector | Health | Financials |
52-Week High | $9.91 | $227.19 |
52-Week Low | $3.78 | $139.09 |
Enterprise Value | -$9.66M | — |
Dividend Yield | — | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Morgan Stanley (MS) trades at $222.28, up 0.07% on the day, with a bullish technical outlook and strong fundamental performance. Recent quarterly earnings consistently beat expectations, with Q1 2026 EPS of $3.43 surpassing the $3.02 estimate. Revenue growth accelerated to $66.0B in 2025, driving net income to $16.9B. The stock benefits from positive analyst sentiment, including involvement in high-profile deals like the Anthropic IPO.
The outlook remains positive given earnings momentum and a consensus price target of $225.80, though risks include volatile cash flows and rising debt levels. Investor sentiment is bolstered by strategic initiatives like AI integration in wealth management, but macroeconomic sensitivity and competitive pressures warrant monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
